What is the current Kymera Therapeutics share price?
The current share price of Kymera Therapeutics is US$ 40.90
How many Kymera Therapeutics shares are in issue?
Kymera Therapeutics has 64,765,274 shares in issue
What is the market cap of Kymera Therapeutics?
The market capitalisation of Kymera Therapeutics is USD 2.53B
What is the 1 year trading range for Kymera Therapeutics share price?
Kymera Therapeutics has traded in the range of US$ 22.35 to US$ 53.27 during the past year
What is the PE ratio of Kymera Therapeutics?
The price to earnings ratio of Kymera Therapeutics is -17.91
What is the cash to sales ratio of Kymera Therapeutics?
The cash to sales ratio of Kymera Therapeutics is 33.49
What is the reporting currency for Kymera Therapeutics?
Kymera Therapeutics reports financial results in USD
What is the latest annual turnover for Kymera Therapeutics?
The latest annual turnover of Kymera Therapeutics is USD 78.59M
What is the latest annual profit for Kymera Therapeutics?
The latest annual profit of Kymera Therapeutics is USD -146.96M
What is the registered address of Kymera Therapeutics?
The registered address for Kymera Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Kymera Therapeutics website address?
The website address for Kymera Therapeutics is www.kymeratx.com
Which industry sector does Kymera Therapeutics operate in?
Kymera Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
